Author Reply: In Response to “De Novo KRAS G12C-Mutant SCLC: A Case Report”
Open Access
- 19 October 2022
- journal article
- letter
- Published by Elsevier in JTO Clinical and Research Reports
- Vol. 3 (11) , 100425
Abstract
No abstract availableFunding Information
- National Comprehensive Cancer Network
This publication has 4 references indexed in Scilit:
- De Novo KRAS G12C–Mutant SCLC: A Case ReportJTO Clinical and Research Reports, 2022
- The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial DesignJNCI: Journal of the National Cancer Institute, 2020
- Effect Sizes of Somatic Mutations in CancerJNCI: Journal of the National Cancer Institute, 2018
- Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trialsOncotarget, 2018